133 related articles for article (PubMed ID: 4618580)
1. Cardiovascular studies of 5-(3-tert-butylamino-2-hydroxy) propoxy-3,4-dihydrocarbostyril hydrochloride (OPC-1085), a new potent beta-adrenergic blocking agent.
Yabuochi Y; Kinoshita D
Jpn J Pharmacol; 1974 Dec; 24(6):853-61. PubMed ID: 4618580
[TBL] [Abstract][Full Text] [Related]
2. [Effects of 5-(3-tert-butylamino-2-hydroxy) propoxy-3,4-dihydrocarbostyril hydrochloride(OPC-1085) on coronary circulation and myocardial metabolism].
Takenaka F; Shintani S; Ishihara T; Higuchi M; Hiraki I
Nihon Yakurigaku Zasshi; 1975 Mar; 71(2):221-30. PubMed ID: 1093960
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of the effects of OPC-1085 and propranolol on isolated guinea pig atrium.
Imanaga I; Sakamoto Y; Tomita T
Jpn J Pharmacol; 1977 Apr; 27(2):227-32. PubMed ID: 18629
[TBL] [Abstract][Full Text] [Related]
4. The inotropic and chronotropic responses of isolated canine atrium to 5-(3-tert.-butylamino-2-hydroxy)propoxy-3,4-dihydrocarbostyril hydrochloride (carteolol).
Chiba S
Arzneimittelforschung; 1979; 29(6):895-7. PubMed ID: 582780
[TBL] [Abstract][Full Text] [Related]
5. Antiarrhythmic properties of 5-(3-tert-butylamino-2-hydroxy)propoxy-3,4-dihydrocarbostyril hydrochloride (OPC-1085), a newly synthesized, potent beta-adrenoreceptor antagonist.
Yabuuchi Y; Hashimoto K; Yamashita S; Uno T; Shintani S; Nakagiri N
Clin Exp Pharmacol Physiol; 1977; 4(6):545-59. PubMed ID: 22416
[TBL] [Abstract][Full Text] [Related]
6. Positive inotropic and negative chronotropic effects of OPC-8490, a newly developed cardiotonic, in isolated, blood-perfused canine heart preparations.
Furukawa Y; Akahane K; Haniuda M; Chiba S
Jpn Heart J; 1989 May; 30(3):387-98. PubMed ID: 2552190
[TBL] [Abstract][Full Text] [Related]
7. Comparison of newly synthesized beta-adrenergic blockers, OPC 1085 and SQ 11725, with pindolol and propranolol in the blood-perfused canine SA node and papillary muscle preparations.
Hashimoto K; Kimura T; Yabuuchi Y
Jpn J Pharmacol; 1976 Aug; 26(4):504-6. PubMed ID: 12390
[No Abstract] [Full Text] [Related]
8. Beta-blocking potency of mepindolol and pindolol against isoproterenol-induced inotropic and chronotropic responses in guinea pig atria.
Anderson WG
J Cardiovasc Pharmacol; 1984; 6(1):7-11. PubMed ID: 6199615
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacological properties of dl-2-(3'-t-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl) thiazole hydrochloride (S-596), a new beta-adrenergic blocking agent (author's transl)].
Hara Y; Sato E; Miyagishi A; Aono S; Nakatani H
Nihon Yakurigaku Zasshi; 1979 Oct; 75(7):707-20. PubMed ID: 94296
[TBL] [Abstract][Full Text] [Related]
10. Estimation of cardiodepressant potency of nadolol, alprenolol, propranolol and pindolol, beta-blocking agents, in heart-lung preparation and blood-perfused excised papillary muscle preparation of the dog.
Ono H; Kanazawa Y; O'Hara N; Hashimoto K
Jpn J Pharmacol; 1984 Dec; 36(4):507-17. PubMed ID: 6151997
[TBL] [Abstract][Full Text] [Related]
11. Effects of metoprolol, alone and in combination with lidocaine, on ventricular fibrillation threshold: comparison with atenolol, propranolol, and pindolol.
Coram WM; Olson RW; Beil ME; Cabot CF; Weiss GB
J Cardiovasc Pharmacol; 1987 May; 9(5):611-21. PubMed ID: 2439844
[TBL] [Abstract][Full Text] [Related]
12. Intrinsic sympathomimetic activity of (-)-pindolol mediated through a (-)-propranolol-resistant site of the beta1-adrenoceptor in human atrium and recombinant receptors.
Joseph SS; Lynham JA; Molenaar P; Grace AA; Colledge WH; Kaumann AJ
Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):496-503. PubMed ID: 14608456
[TBL] [Abstract][Full Text] [Related]
13. Centrally induced hypotensive effects of beta-adrenergic blocking drugs.
Garvey HL; Ram N
Eur J Pharmacol; 1975; 33(2):283-94. PubMed ID: 241653
[TBL] [Abstract][Full Text] [Related]
14. Effects of dopamine on sinus rate and ventricular contractile force of the dog heart in vitro and in vivo.
Endoh M
Br J Pharmacol; 1975 Dec; 55(4):475-86. PubMed ID: 1212559
[TBL] [Abstract][Full Text] [Related]
15. The beta-adrenoceptor stimulant properties of OPC-2009 on guinea-pig isolated tracheal, right atrial and left atrial preparations.
Yabuuchi Y
Br J Pharmacol; 1977 Dec; 61(4):513-21. PubMed ID: 23191
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic antagonism of beta-adrenergic blockade in dogs. I. Hemodynamic effects of isoproterenol, dopamine, and epinephrine in acute propranolol administration.
Avery GJ; Spotnitz HM; Rose EA; Malm JR; Hoffman BF
J Thorac Cardiovasc Surg; 1979 Feb; 77(2):267-76. PubMed ID: 33298
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo studies of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, in various animals.
Yamashita S; Hosokawa T; Kojima M; Mori T; Yabuuchi Y
Arzneimittelforschung; 1984; 34(3A):342-6. PubMed ID: 6331464
[TBL] [Abstract][Full Text] [Related]
18. Vanidipinedilol: a vanilloid-based beta-adrenoceptor blocker displaying calcium entry blocking and vasorelaxant activities.
Yeh JL; Liou SF; Liang JC; Huang YC; Chiang LC; Wu JR; Lin YT; Chen IJ
J Cardiovasc Pharmacol; 2000 Jan; 35(1):51-63. PubMed ID: 10630733
[TBL] [Abstract][Full Text] [Related]
19. The cardiovascular pharmacology and hemodynamic activity of tazolol, a selective myocardial beta-stimulant.
Strosberg AM
Arch Int Pharmacodyn Ther; 1976 Aug; 222(2):200-15. PubMed ID: 10864
[TBL] [Abstract][Full Text] [Related]
20. Derivatives of 3,4-dihydrocarbostyril as beta-adrenergic blocking agents.
Nakagawa K; Murakami N; Yoshizaki S; Tominaga M; Mori H
J Med Chem; 1974 May; 17(5):529-33. PubMed ID: 4151493
[No Abstract] [Full Text] [Related]
[Next] [New Search]
